Back

Prognostic value of dipyridamole stress CMR in patients with known or suspected coronary artery disease: a long term follow-up study

2 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Abstract session 1: value of CMR stress perfusion: latest evidence Stress Cardiac Magnetic Resonance (CMR) EACVI Premium Access EuroCMR 2019

About the speaker

Photo
Assistant Professor Alessia Pepe

Tuscany Monasterio Foundation National Research Council, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail
Myocardial perfusion defects in genotype-positive hypertrophic cardiomyopathy without left ventricular hypertrophy
Doctor R. Hughes (London, GB)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance for evaluating non-culprit lesions after acute myocardial infarction: a comparison with fractional flow reserve
Mr H. Everaars (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Relationship between exercise capacity and LV mechanics in patients with precapillary pulmonary hypertension-a regadenoson hyperemic-stress CMR study
Doctor A. Florian (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Feasibility and prognostic value of vasodilator stress perfusion CMR in elderly patients > 75 years without known CAD
Doctor T. Pezel (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Abstract session 1: value of CMR stress perfusion: latest evidence

The Event

Event poster

EuroCMR 2019

2 May - 4 May 2019
You may be interested in
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment
thumbnail
Congress Presentation
Practical opportunities to optimise outcomes in stress cardiac MR
thumbnail
Congress Presentation
CMR in the chronic coronary syndrome guidelines

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources